New cytochalasins: Synthetic studies of a novel HIV-1 protease inhibitor

Tetrahedron Letters

Volumn 37, Issue 24, 1996, Pages 4113-4116

  Hungate, Randall W ^a   Chen, Jenny L ^a   Starbuck, Ken E ^a   Macaluso, Sally A ^a   Rubino, Robert S ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHALASIN; PROTEINASE INHIBITOR; TITANIUM; VIRUS ENZYME;

ARTICLE; DRUG CYTOTOXICITY; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; STRUCTURE ACTIVITY RELATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0029952352     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/0040-4039(96)00778-2     Document Type: Article

References (42)

1. (a) Dombrowski, A. W.; Bills, G. F.; Sabnis, G.; Koupal, L. R.; Meyer, R.; Ondeka, J. G.; Giacobbe, R. A.; Monaghan, R. L.; Lingham, R. B. J. Antibiot. 1992, 45, 671-678.
2. (b) Ondeka, J. G.; Hensens, O. D.; Zink, D.; Ball, R.; Lingham, R. B.; Bills, G. F.; Dombrowski, A.; Goetz, M. J. Antibiot. 1992, 45 679-685.
3. (c) Lingham, R. B.; Hsu, A.; Silverman, K. C.; Bills, G. F.; Dombrowski, A.; Goldman, M. E.; Darke, P. L.; Huang, L.; Koch, G.; Ondeka, J. G. J. Antibiot. 1992, 45, 686-691.
4. (a) Huff, J. R. J. Med. Chem. 1991, 34, 2305-2314.
5. (b) Norbeck, D. W.; Kempf, D. J. In Annual Reports in Medicinal Chemistry; Bristol, J. A., Ed.; Academic Press, San Diego, 1991; pp. 141-150.
6. (c) Wlodawer, A.; Erickson, J. W. A. Rev. Biochem. 1993, 62, 543-585.
7. (a) Kohl, N. E.; Eminio, E. A.; Schleif, W. A.; Davis, L. J.; Heimbach, J. L.; Dixon, R. A. F.; Scolnick, E. M.; Sigal, I. S. Proc. Natl. Acad. Sci. USA 1988, 85, 4686-4690.
8. (b) Seelmeier, S.; Schmidt, H.; Turk, V.; von der Helm, K. Proc. Natl. Acad. Sci. USA 1988, 55, 6612-6616.
9. (c) McQuade, T. J.; Tomaselli, A. G.; Liu, L.; Karactstas, V.; Moss, B.; Sawyer, T. K.; Heinrikson, R. L.; Tarpley, W. G. Science 1990, 247, 454-456.
10. For some exceptions see Erickson, J. W.; Fesik, S. W. In Annual Reports in Medicinal Chemistry; Venuti, M. C., Ed.; Academic Press, San Diego, 1992; pp. 271-289, Potts, C. M.; Faulkner, D. J.; Chan, J. A.; Simolike, G. C.; Offen, P.; Hemling, M. E.; Francis, T. A. J. Am. Chem. Soc. 1991, 113, 6321-6322. Kuntz, I. D. Science 1992, 257, 1078-1082.
11. For some exceptions see Erickson, J. W.; Fesik, S. W. In Annual Reports in Medicinal Chemistry; Venuti, M. C., Ed.; Academic Press, San Diego, 1992; pp. 271-289, Potts, C. M.; Faulkner, D. J.; Chan, J. A.; Simolike, G. C.; Offen, P.; Hemling, M. E.; Francis, T. A. J. Am. Chem. Soc. 1991, 113, 6321-6322. Kuntz, I. D. Science 1992, 257, 1078-1082.
12. For some exceptions see Erickson, J. W.; Fesik, S. W. In Annual Reports in Medicinal Chemistry; Venuti, M. C., Ed.; Academic Press, San Diego, 1992; pp. 271-289, Potts, C. M.; Faulkner, D. J.; Chan, J. A.; Simolike, G. C.; Offen, P.; Hemling, M. E.; Francis, T. A. J. Am. Chem. Soc. 1991, 113, 6321-6322. Kuntz, I. D. Science 1992, 257, 1078-1082.
13. For some recent examples of non-peptide based inhibitors that have appeared since much of this work was completed see (a) Chenera, B.; DesJarlais, R. L.; Finkelstein, J. A.; Eggleston, D. S.; Meek, T. D.; Tomaszek, T. A.; Dreyer, G. B. Bioorg. Med. Chem. Lett. 1993, 3 (12), 2717-2722.
14. (b) Lam, P. Y.-S.; Jadhav, P. K.; Eyermann, C. J.; Hodge, C. N.; Ru, Y.; Bacheler, L. T.; Meek, J. L.; Otto, M. J.; Rayner, M. M.; Wong, Y. N.; Chang, C-H.; Weber, P. C.; Jackson, D. A.; Sharpe, T. R.; Erickson-Vitanen, S. Science 1994, 263, 380-384.
15. (c) Holmes, D. S.; Clemens, I. R.; Cobley, K. N.; Humber, D. C.; Kitchin, J.; Orr, D. C.; Patel, B.; Paternoster, I. L.; Storer, R. Bioorg. Med. Chem. Lett. 1993, 3 (4), 503-508.
16. (d) Vara Prasad, J. V. N.; Para, K. S.; Lunney, E. A.; Ortwine, D. F.; Dunbar, J. B., Jr.; Ferguson, D.; Tummino, P. J.; Hupe, D.; Tait, B. D.; Domagala, J. M.; Humblet, C.; Bhat, T. N.; Liu, B.; Guerin, D. M. A.; Baldwin, E. T.; Erickson, J. W.; Sawyer, T. K. J. Am. Chem. Soc. 1994, 116 (15), 6989-6990. Thaisrivongs, S.; Tomich, P. K.; Watenpaugh, K. D.; Chong, K.-T.; Howe, W. J.; Yang, C.-P.; Strohbach, J. W.; Turner, S. R.; McGrath, J. P.; Bohanon, M. J.; Lynn, J. C.; Mulichak, A. M.; Spinelli, P. A.; Hinshaw, R. R.; Pagano, P. J.; Moon, J. B.; Ruwart, M. J.; Wilkinson, K. F.; Rush, B. D.; Zipp, G. L.; Dalga, R. J.; Schwende, F. J.; Howard, G. M.; Padbury, G. E.; Toth, L. N.; Zhao, Z.; Koeplinger, K. A.; Kakuk, T. J.; Cole, S. L.; Zaya, R. M.; Piper, R. C.; Jeffery, P. J. Med. Chem. 1994, 37, 3200-3204.
17. (d) Vara Prasad, J. V. N.; Para, K. S.; Lunney, E. A.; Ortwine, D. F.; Dunbar, J. B., Jr.; Ferguson, D.; Tummino, P. J.; Hupe, D.; Tait, B. D.; Domagala, J. M.; Humblet, C.; Bhat, T. N.; Liu, B.; Guerin, D. M. A.; Baldwin, E. T.; Erickson, J. W.; Sawyer, T. K. J. Am. Chem. Soc. 1994, 116 (15), 6989-6990. Thaisrivongs, S.; Tomich, P. K.; Watenpaugh, K. D.; Chong, K.-T.; Howe, W. J.; Yang, C.-P.; Strohbach, J. W.; Turner, S. R.; McGrath, J. P.; Bohanon, M. J.; Lynn, J. C.; Mulichak, A. M.; Spinelli, P. A.; Hinshaw, R. R.; Pagano, P. J.; Moon, J. B.; Ruwart, M. J.; Wilkinson, K. F.; Rush, B. D.; Zipp, G. L.; Dalga, R. J.; Schwende, F. J.; Howard, G. M.; Padbury, G. E.; Toth, L. N.; Zhao, Z.; Koeplinger, K. A.; Kakuk, T. J.; Cole, S. L.; Zaya, R. M.; Piper, R. C.; Jeffery, P. J. Med. Chem. 1994, 37, 3200-3204.
18. (a) Tamm, C. Cytochalasins, Biochemical and Cell Biological Aspects; In Frontiers of Biology, Tanenbaum, S. W., Ed.; North Holland Publishing Co.: Amsterdam 1978; Vol. 46, pp. 15
19. (b) Mujumdar, A. M. Hind. Antibiot. Bull. 1989, 31 (1-2) 15-24.
20. (a) Bloch, R. Biochemistry, 1973, 12, 4799-4801.
21. (b) Taverna, R. D.; Langdon, R. G. Biochim. Biophys. Acta. 1973, 323, 207-219.
22. (a) Cooper, J. A. J. Cell. Biol. 1987, 105, 1473-1478.
23. (b) Brown, S. S.; Spudich, J. A. J. Cell. Biol. 1981, 88, 487-491.
24. (c) Goddette, D. W.; Frieden, C. J. Biol. Chem. 1986, 261, 15974-15980.
25. For a recent example of cytochalasin B as a probe of the galactose/H+ transporter in E.Coli see: Cairns, M. T.; McDonald, T. P.; Horne, P.; Henderson, P. J. F; Baldwin, S. A. J. Biol. Chem. 1991, 266, 8176-8183.
26. Colleagues have recently described work on the natural product. Kim, B. M.; Guare, J. P.; Pitzenberger, S. M. Heterocycles 1995, 41 (3), 409-414.
27. (a) Weinreb, S. M.; Kim, M.Y. Tetrahedron Lett. 1979, 20, 579-582.
28. (b) Weinreb, S. M.; Kim, M.Y.; Starret, J. E. J. Org. Chem. 1981, 46, 5383-5389. In a somewhat related approach to functionalizing C-10 Tamm and co-workers have described an approach from glutamic acid. Tamm, C.; Ackermann, J.; Matthes, M. Helv. Chim. Acta. 1990, 73, 122-132.
29. (b) Weinreb, S. M.; Kim, M.Y.; Starret, J. E. J. Org. Chem. 1981, 46, 5383-5389. In a somewhat related approach to functionalizing C-10 Tamm and co-workers have described an approach from glutamic acid. Tamm, C.; Ackermann, J.; Matthes, M. Helv. Chim. Acta. 1990, 73, 122-132.
30. (a) For a recent review see Thomas, E. J. Acc. Chem. Res. 1991, 24, 229-235 and references therein.
31. See also (b) Vedejs, E.; Reid, J. G.; Rodgers, J. D.; Wittenberger, S. J. J. Am. Chem. Soc. 1990, 112, 4351-4357.
32. (c) Vedejs, E.; Wittenberger, S. J. ibid. 1990, 112, 4357-4364.
33. (d) Trost, B. M.; Ohmori, M.; Boyd, S. A.; Okawara, H.; Brickner, S. J. ibid. 1989, 111, 8281-8284.
34. Takacs, J. M.; Weidner, J. J. J. Org. Chem. 1994, 59, 6480-6483 and references therein.
35. See for example Ishibuchi, S.; Ikematsu, Y.; Ishizuka, T.; Kunieda, T. Tetrahedron Lett. 1991, 32, 3523-3526.
36. (a) Lipshutz, B. H.; Ellsworth, E. L.; Dimock, S. H.; Smith, R. A. J. J. Am. Chem. Soc. 1990, 112, 4404-4410.
37. (b) Lipshutz, B. H.; Ellsworth, E. L.; Dimock, S. H.; Smith, R. A. J. J. Org. Chem. 1989, 54, 4977-4979. See also Mehta, B. K.; Ila, H.; Junjappa, H. Tetraherdon Lett. 1995, 36(11), 1925-1928. The stereochemistry was anticipated based on the conformation of the intermediate iminium ion, but was rigorously established using a combination of NMR techniques. Cosy and hmqc spectra were recorded at 500MHz.
38. (b) Lipshutz, B. H.; Ellsworth, E. L.; Dimock, S. H.; Smith, R. A. J. J. Org. Chem. 1989, 54, 4977-4979. See also Mehta, B. K.; Ila, H.; Junjappa, H. Tetraherdon Lett. 1995, 36(11), 1925-1928. The stereochemistry was anticipated based on the conformation of the intermediate iminium ion, but was rigorously established using a combination of NMR techniques. Cosy and hmqc spectra were recorded at 500MHz.
39. Evans, D. A.; Urpi, F.; Somers, T. C.; Clark, J. S.; Bilodeau J. J. Am. Chem. Soc. 1990, 112, 8215-8216. Evans, D. A.; Rieger, D. L.; Bilodeau, J.; Urpi, F. J. Am. Chem. Soc. 1991, 113, 1047-1050.
40. Evans, D. A.; Urpi, F.; Somers, T. C.; Clark, J. S.; Bilodeau J. J. Am. Chem. Soc. 1990, 112, 8215-8216. Evans, D. A.; Rieger, D. L.; Bilodeau, J.; Urpi, F. J. Am. Chem. Soc. 1991, 113, 1047-1050.
41. Further manipulations to produce functionalities present in the natural product but lacking the macrocyclic ring were achieved using procedures described in the literature. For example see reference 10b.
42. None of the intermediates shown or analogs which lack the macrocyclic ring were active in the enzyme inhibition assay. Portions of that work has been published in: Advanced ACS Abstracts August 1993.